Tevogen bio holdings inc.TVGN.US Overview

US StockHealthcare

(No presentation for TVGN)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

TVGN Overall Performance

TVGN AI Analysis & Strategy

TVGN Recent Performance

2.65%

Tevogen bio holdings inc.

0.81%

Avg of Sector

-1.14%

S&P500

TVGN PowerScanner

TVGN Key Information

TVGN Valuation Metrics

TVGN Earnings Table

TVGN Profile

Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.